Adverse outcomes among Aboriginal patients receiving peritoneal dialysis

被引:19
|
作者
Sood, Manish M. [1 ]
Komenda, Paul [2 ]
Sood, Amy R. [3 ]
Reslerova, Martina [2 ]
Verrelli, Mauro [2 ]
Sathianathan, Chris [2 ]
Eng, Loretta [2 ]
Eng, Amanda [2 ]
Rigatto, Claudio [4 ]
机构
[1] St Boniface Gen Hosp, Dept Med, Winnipeg, MB R3X 1Y2, Canada
[2] St Boniface Gen Hosp, Dept Nephrol, Winnipeg, MB R3X 1Y2, Canada
[3] St Boniface Gen Hosp, Dept Pharm, Winnipeg, MB R3X 1Y2, Canada
[4] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; STAGE RENAL-DISEASE; 1ST NATIONS PEOPLE; HEMODIALYSIS; PREDICTORS; AUSTRALIA; MORTALITY; RISK; PREVALENCE; CANADIANS;
D O I
10.1503/cmaj.100105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Aboriginal population in Canada experiences high rates of end-stage renal disease and need for dialytic therapies. Our objective was to examine rates of mortality, technique failure and peritonitis among adult aboriginal patients receiving peritoneal dialysis in the province of Manitoba. We also aimed to explore whether differences in these rates may be accounted for by location of residence (i.e., urban versus rural). Methods: We included all adult patients residing in the province of Manitoba who received peritoneal dialysis during the period from 1997-2007 (n = 727). We extracted data from a local administrative database and from the Canadian Organ Replacement Registry and the Peritonitis Organism Exit-sites/Tunnel infections (POET) database. We used Cox and logistic regression models to determine the relationship between outcomes and Aboriginal ethnicity. We performed Kaplan-Meier analyses to examine the relationship between outcomes and urban (i.e., 50 km or less from the primary dialysis centre in Winnipeg) versus rural (i.e., more than 50 km from the centre) residency among patients who were aboriginal. Results: One hundred sixty-one Aboriginal and 566 non-Aboriginal patients were included in the analyses. Adjusted hazard ratios for mortality (HR 1.476, CI 1.073-2.030) and adjusted time to peritonitis (HR 1.785, CI 1.352-2.357) were significantly higher among Aboriginal patients than among non-Aboriginal patients. We found no significant differences in mortality, technique failure or peritonitis between urban-or rural-residing Aboriginal patients. Interpretation: Compared with non-Aboriginal patients receiving peritoneal dialysis, Aboriginal patients receiving peritoneal dialysis had higher mortality and faster time to peritonitis independent of comorbidities and demographic characteristics. This effect was not influenced by place of residence, whether rural or urban.
引用
收藏
页码:1433 / 1439
页数:7
相关论文
共 50 条
  • [1] Use and outcomes of peritoneal dialysis among aboriginal people in Canada
    Tonelli, M
    Hemmelgarn, B
    Manns, B
    Davison, S
    Bohm, C
    Gourishankar, S
    Pylypchuk, G
    Yeates, K
    Gill, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02): : 482 - 488
  • [2] Prevalence and adverse outcomes of hypokalemia and the role of potassium supplementation in patients receiving peritoneal dialysis
    Yang, Changyuan
    Hu, Xiaoxuan
    Ling, Xitao
    Xiao, Cuixia
    Duan, Ruolan
    Qiu, Jiamei
    Qin, Xindong
    Liu, Xusheng
    Lindholm, Bengt
    Johnson, David W.
    Lu, Fuhua
    Su, Guobin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I149 - I150
  • [3] Prevalence and adverse outcomes of hypokalemia and the role of potassium supplementation in patients receiving peritoneal dialysis
    Yang, Changyuan
    Hu, Xiaoxuan
    Ling, Xitao
    Xiao, Cuixia
    Duan, Ruolan
    Qiu, Jiamei
    Qin, Xindong
    Liu, Xusheng
    Lindholm, Bengt
    Johnson, David W.
    Lu, Fuhua
    Su, Guobin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [4] Cardiac Surgery Outcomes in Patients Receiving Hemodialysis Versus Peritoneal Dialysis
    Bassil, Elias
    Matta, Milad
    El Gharably, Haytham
    Harb, Serge
    Calle, Juan
    Arrigain, Susana
    Schold, Jesse
    Taliercio, Jonathan
    Mehdi, Ali
    Nakhoul, Georges
    KIDNEY MEDICINE, 2024, 6 (03)
  • [5] Developing a Predictive Model for Adverse Outcomes for Patients on Peritoneal Dialysis (PD)
    Blair, Alex
    Dai, Yang
    Wen, Huei Hsun
    Wu, Eric
    Nadkarni, Girish N.
    Sharma, Shuchita
    Uribarri, Jaime
    Chan, Lili
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 456 - 456
  • [6] Dietary Potassium and Clinical Outcomes among Patients on Peritoneal Dialysis
    Pan, Jinru
    Xu, Xiao
    Wang, Zi
    Ma, Tiantian
    Dong, Jie
    NUTRIENTS, 2023, 15 (19)
  • [7] Scope and heterogeneity of outcomes reported in randomized trials in patients receiving peritoneal dialysis
    Manera, Karine E.
    Johnson, David W.
    Cho, Yeoungjee
    Sautenet, Benedicte
    Shen, Jenny
    Kelly, Ayano
    Wang, Angela Yee-Moon
    Brown, Edwina A.
    Brunier, Gillian
    Perl, Jeffrey
    Dong, Jie
    Wilkie, Martin
    Mehrotra, Rajnish
    Pecoits-Filho, Roberto
    Naicker, Saraladevi
    Dunning, Tony
    Craig, Jonathan C.
    Tong, Allison
    CLINICAL KIDNEY JOURNAL, 2021, 14 (07) : 1817 - 1825
  • [8] IMPACT OF ARTERIAL STIFFNESS ON ADVERSE CARDIOVASCULAR OUTCOMES AND MORTALITY IN PERITONEAL DIALYSIS PATIENTS
    Sipahioglu, Murat H.
    Kucuk, Hamit
    Unal, Aydin
    Kaya, Mehmet G.
    Oguz, Fatih
    Tokgoz, Bulent
    Oymak, Oktay
    Utas, Cengiz
    PERITONEAL DIALYSIS INTERNATIONAL, 2012, 32 (01): : 73 - 80
  • [9] Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis patients
    Kaya, M. G.
    Sipahioglu, M.
    Kucuk, H.
    Unal, A.
    Oguz, F.
    Tokgoz, B.
    Oymak, O.
    Utas, C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 768 - 769
  • [10] IMPACT OF CENTRAL OBESITY AND FRAILTY ON ADVERSE CLINICAL OUTCOMES IN PERITONEAL DIALYSIS PATIENTS
    Chan, Chun Kau Gordon
    NEPHROLOGY, 2020, 25 : 89 - 90